Oral glucose tolerance testing in Cystic Fibrosis

Not Applicable

Completed

• Conditions: Cystic Fibrosis; Diabetes; Respiratory - Other respiratory disorders / diseases; Metabolic and Endocrine - Diabetes; Human Genetics and Inherited Disorders - Cystic fibrosis

• Registration Number: ACTRN12614000064606
• Lead Sponsor: Dr Odette Erskine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-01-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Diagnosis of Cystic Fibrosis
2. At least one OGTT and lung function testing - these tests were performed at any time in the past.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Document the prevalence and incidence of impaired glucose tolerance and diabetes in subjects with Cystic Fibrosis at age of 18-21 years.<br>OGTT was measured at baseline and at a subsequent time period (approximately 2-3 years). [Baseline and at a subsequent time period (approximately 2-3 years).]

Secondary Outcome Measures

Name	Time	Method
Document the trend of blood glucose levels in subjects with Cystic Fibrosis[Baseline to follow-up/subsequent review (approximately 2-3 years).];Document the relationship of the results of the OGTT with lung function.<br>OGTT was performed and spirometry performed according to the ATS guidelines. [Baseline];Document trend of lung function in association with trend of glucose intolerance. <br>OGTT was performed and spirometry performed according to the ATS guidelines. The results at baseline were compared with the results 2-3 years later.[Baseline to follow-up/subsequent review (approximately 2-3 years).]